Article Details

NEA Backs Startup's Software to Assess Drug Performance

Retrieved on: 2018-04-10 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

NEA Backs Startup's Software to Assess Drug Performance. View article details on hiswai:

Excerpt

<div><b>New Enterprise Associates</b> led the round as a first-time investor alongside Amgen Ventures. Existing investors Flare Capital Partners, Lakestar and Oxeon Ventures also contributed, bringing Aetion's total raised to date to $50 million. NEA General Partner Mohamad Makhzoumi, who will join the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up